Kristin M. Beale, Ph.D.

Lupin Announces Licensing Deal With Sandoz For Ranibizumab Biosimilar

Biosimilar Approval Updates In Europe And China

Celltrion Announces Commercial Availability Of ZYMFENTRA™ (Infliximab-dyyb)

Merck To Buy Harpoon Therapeutics For $680 Million

Regeneron Sues Formycon AG For Proposed Biosimilar Of EYLEA In West Virginia District Court

FDA Approves VABYSMO (Faricimab) For Retinal Vein Occlusion

Sandoz Receives FDA Approval For Tyruko® (Natalizumab-Sztn), The First And Only FDA-Approved Biosimilar For Relapsing Forms Of Multiple Sclerosis

Amgen Files BPCIA Complaint Against Sandoz Regarding Denosumab

Alkem Subsidiary Enzene Launches Adalimumab Biosimilar In India